International Stem Cell Corporation v. Comptroller General of Patents, Designs and Trade Marks
European Union Court of Justice
Case C-364/13 (2014)
- Written by Eric Miller, JD
Facts
The International Stem Cell Corporation (ISCO) (plaintiff) applied for two patents involving artificial parthenogenesis—a form of asexual reproduction. However, the type of human ova (i.e., female egg cells) used in ISCO’s processes were not capable of commencing the process of developing a human being. The patent court of the United Kingdom rejected the applications on the ground that human embryos were not patentable under European Union (EU) law. The matter was appealed to the EU Court of Justice for a preliminary ruling. ISCO argued that the rule against patentability of human embryos applied only to organisms that were capable of developing into a human being.
Rule of Law
Issue
Holding and Reasoning (Per curiam)
What to do next…
Here's why 832,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,500 briefs, keyed to 994 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.